subscribe: Posts | Comments

Black, Hispanic and poor women in the US at higher risk of cervical cancer

0 comments

Summary of story from Health Behavior News Service, August 30, 2011

A new study by the Yale School of Public Health has identified barriers preventing young African-Amercan, Hispanic and poor women in the US from completing a series of three vaccinations against human papillomavirus infection (HPV).

This leaves them at a higher risk of cervical cancer and death.

The study, to be published in the October issue of the American Journal of Preventive Medicine, uses data collected from the US federal government’s 2008-2009 National Immunisation Survey on teen girls who received at least one dose of HPV vaccine.

During that period, 55 per cent of the adolescents received all three doses, 21 per cent received one dose and 24 per cent received two. While not ideal, the authors cited an “encouraging” annual completion rate increase from the first study year to the second.

Although previous reports have shown that aforementioned groups are more likely than their white counterparts to receive the first dose, many do not come back for the next two doses – despite the cost being covered by the vaccine programme for low-income families.

The lead study author, Linda Niccolai, an associate professor of epidemiology has said:

“…to complete the series requires knowledge, motivation and the belief that it’s important, even though the cost is covered.

“Deterrents to vaccination completion at additional visits might include office visit co-payments, transportation issues or parents’ inability to take time off work. Something keeps them from returning two more times.”

According to the Centers for Disease Control and Prevention, HPV is the most common sexually transmitted infection and at least 50 per cent of sexually active men and women get it at some point in their lives.

Persistent HPV infections are the primary cause of cervical cancer. In the United States, clinicians diagnose approximately 12,000 new cervical cancer cases each year, resulting in about 4,000 deaths, according to the CDC.

Leave a Reply

Your email address will not be published. Required fields are marked *